These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 2674438

  • 1. Drug interactions with ACE inhibitors.
    Breckenridge AM.
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():133-8. PubMed ID: 2674438
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A, Pedrinelli R, Arzilli F, Abdel-Haq B, Magagna A, Lucarini A, Graziadei L, Nuccorini A, Taddei S.
    Int J Clin Pharmacol Res; 1985 Oct; 5(6):429-38. PubMed ID: 3005182
    [Abstract] [Full Text] [Related]

  • 5. Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update.
    Song JC, White CM.
    Clin Pharmacokinet; 2002 Oct; 41(3):207-24. PubMed ID: 11929321
    [Abstract] [Full Text] [Related]

  • 6. Critical assessment of ACE inhibitors. Part 2.
    Howes LG.
    Aust Fam Physician; 1995 Apr; 24(4):639, 641-3. PubMed ID: 7771972
    [Abstract] [Full Text] [Related]

  • 7. [Clinical pharmacology of ACE inhibitors].
    Hitzenberger G.
    Wien Med Wochenschr; 1990 Jan 31; 140(1-2):12-8. PubMed ID: 2408245
    [Abstract] [Full Text] [Related]

  • 8. Pharmacologic, pharmacokinetic, and therapeutic differences among ACE inhibitors.
    White CM.
    Pharmacotherapy; 1998 Jan 31; 18(3):588-99. PubMed ID: 9620109
    [Abstract] [Full Text] [Related]

  • 9. The pharmacokinetics of angiotensin converting enzyme inhibitors in patients with renal impairment.
    Begg EJ, Bailey RR, Lynn KL, Robson RA, Frank GJ, Olson SC.
    J Hypertens Suppl; 1989 Sep 31; 7(5):S29-32. PubMed ID: 2681603
    [Abstract] [Full Text] [Related]

  • 10. Lisinopril: a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Noble TA, Murray KM.
    Clin Pharm; 1988 Sep 31; 7(9):659-69. PubMed ID: 2853660
    [Abstract] [Full Text] [Related]

  • 11. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.
    Grinshtein SV, Binevski PV, Gomazkov OA, Pozdnev VF, Nikolskaya II, Kost OA.
    Biochemistry (Mosc); 1999 Aug 31; 64(8):938-44. PubMed ID: 10498812
    [Abstract] [Full Text] [Related]

  • 12. The clinical pharmacology of lisinopril.
    Case DE.
    J Hum Hypertens; 1989 Jun 31; 3 Suppl 1():127-31. PubMed ID: 2550635
    [Abstract] [Full Text] [Related]

  • 13. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
    Westendorp B, Schoemaker RG, van Gilst WH, van Veldhuisen DJ, Buikema H.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):141-9. PubMed ID: 16310764
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
    Udupa EG, Rao NM.
    Indian J Biochem Biophys; 1997 Dec 19; 34(6):524-8. PubMed ID: 9594434
    [Abstract] [Full Text] [Related]

  • 15. Impact of disease states on the pharmacokinetics and pharmacodynamics of angiotensin-converting enzyme inhibitors.
    LeBlanc JM, Dasta JF, Pruchnicki MC, Schentag JJ.
    J Clin Pharmacol; 2006 Sep 19; 46(9):968-80. PubMed ID: 16920891
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetic optimisation of angiotensin converting enzyme (ACE) inhibitor therapy.
    Burnier M, Biollaz J.
    Clin Pharmacokinet; 1992 May 19; 22(5):375-84. PubMed ID: 1505143
    [Abstract] [Full Text] [Related]

  • 17. Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report.
    Karlberg BE, Fyhrquist F, Grönhagen-Riska C, Tikkanen I, Ohman KP.
    Scand J Urol Nephrol Suppl; 1984 May 19; 79():103-6. PubMed ID: 6089307
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin-converting enzyme inhibitors: a comparative review.
    Raia JJ, Barone JA, Byerly WG, Lacy CR.
    DICP; 1990 May 19; 24(5):506-25. PubMed ID: 2188439
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin converting enzyme inhibitor-induced renal dysfunction: recommendations for prevention.
    Cooke HM, De Besse A.
    Int J Clin Pharmacol Ther; 1994 Feb 19; 32(2):65-70. PubMed ID: 8004361
    [Abstract] [Full Text] [Related]

  • 20. High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese.
    Woo KS, Nicholls MG.
    Br J Clin Pharmacol; 1995 Aug 19; 40(2):141-4. PubMed ID: 8562296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.